ID   S5A2_RAT                Reviewed;         254 AA.
AC   P31214;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   02-OCT-2024, entry version 157.
DE   RecName: Full=3-oxo-5-alpha-steroid 4-dehydrogenase 2;
DE            EC=1.3.1.22 {ECO:0000269|PubMed:1527072};
DE   AltName: Full=5 alpha-SR2;
DE   AltName: Full=SR type 2;
DE   AltName: Full=Steroid 5-alpha-reductase 2;
DE            Short=S5AR 2;
GN   Name=Srd5a2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=1527072; DOI=10.1016/s0021-9258(18)41809-1;
RA   Normington K., Russell D.W.;
RT   "Tissue distribution and kinetic characteristics of rat steroid 5 alpha-
RT   reductase isozymes. Evidence for distinct physiological functions.";
RL   J. Biol. Chem. 267:19548-19554(1992).
CC   -!- FUNCTION: Converts testosterone (T) into 5-alpha-dihydrotestosterone
CC       (DHT) and progesterone or corticosterone into their corresponding 5-
CC       alpha-3-oxosteroids (PubMed:1527072). It plays a central role in sexual
CC       differentiation and androgen physiology (By similarity).
CC       {ECO:0000250|UniProtKB:P31213, ECO:0000269|PubMed:1527072}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 3-oxo-5alpha-steroid + NADP(+) = a 3-oxo-Delta(4)-steroid +
CC         H(+) + NADPH; Xref=Rhea:RHEA:54384, ChEBI:CHEBI:13601,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:47909, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.3.1.22;
CC         Evidence={ECO:0000269|PubMed:1527072};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-hydroxy-5alpha-androstan-3-one + NADP(+) = H(+) + NADPH
CC         + testosterone; Xref=Rhea:RHEA:50820, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16330, ChEBI:CHEBI:17347, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.3.1.22;
CC         Evidence={ECO:0000269|PubMed:1527072};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:50822;
CC         Evidence={ECO:0000305|PubMed:1527072};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5alpha-pregnane-3,20-dione + NADP(+) = H(+) + NADPH +
CC         progesterone; Xref=Rhea:RHEA:21952, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17026, ChEBI:CHEBI:28952, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.3.1.22;
CC         Evidence={ECO:0000269|PubMed:1527072};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:21954;
CC         Evidence={ECO:0000305|PubMed:1527072};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=74 nM for testosterone {ECO:0000269|PubMed:1527072};
CC         KM=42 nM for progesterone {ECO:0000269|PubMed:1527072};
CC         KM=170 nM for androstenedione {ECO:0000269|PubMed:1527072};
CC         KM=376 nM for corticosterone {ECO:0000269|PubMed:1527072};
CC         KM=11.2 uM for cortisol {ECO:0000269|PubMed:1527072};
CC         Vmax=0.5 nmol/min/mg enzyme {ECO:0000269|PubMed:1527072};
CC       pH dependence:
CC         Optimally active at acidic pHs. {ECO:0000269|PubMed:1527072};
CC   -!- SUBCELLULAR LOCATION: Microsome membrane; Multi-pass membrane protein.
CC       Endoplasmic reticulum membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in high levels in the prostate and many
CC       other androgen-sensitive tissues. {ECO:0000269|PubMed:1527072}.
CC   -!- SIMILARITY: Belongs to the steroid 5-alpha reductase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M95058; AAA42182.1; -; mRNA.
DR   PIR; A44104; A44104.
DR   RefSeq; NP_073202.1; NM_022711.4.
DR   AlphaFoldDB; P31214; -.
DR   SMR; P31214; -.
DR   STRING; 10116.ENSRNOP00000009254; -.
DR   BindingDB; P31214; -.
DR   ChEMBL; CHEMBL5099; -.
DR   DrugCentral; P31214; -.
DR   PhosphoSitePlus; P31214; -.
DR   PaxDb; 10116-ENSRNOP00000009254; -.
DR   Ensembl; ENSRNOT00000008983.8; ENSRNOP00000009254.4; ENSRNOG00000027042.7.
DR   Ensembl; ENSRNOT00055035273; ENSRNOP00055028595; ENSRNOG00055020662.
DR   Ensembl; ENSRNOT00060021711; ENSRNOP00060017178; ENSRNOG00060012768.
DR   Ensembl; ENSRNOT00065035212; ENSRNOP00065028325; ENSRNOG00065020764.
DR   GeneID; 64677; -.
DR   KEGG; rno:64677; -.
DR   UCSC; RGD:621480; rat.
DR   AGR; RGD:621480; -.
DR   CTD; 6716; -.
DR   RGD; 621480; Srd5a2.
DR   eggNOG; KOG1638; Eukaryota.
DR   GeneTree; ENSGT00950000182886; -.
DR   HOGENOM; CLU_065395_1_1_1; -.
DR   InParanoid; P31214; -.
DR   OMA; SYGKHTE; -.
DR   OrthoDB; 152402at2759; -.
DR   PhylomeDB; P31214; -.
DR   TreeFam; TF314668; -.
DR   BRENDA; 1.3.1.22; 5301.
DR   Reactome; R-RNO-193048; Androgen biosynthesis.
DR   SABIO-RK; P31214; -.
DR   PRO; PR:P31214; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000027042; Expressed in duodenum and 4 other cell types or tissues.
DR   GO; GO:0070852; C:cell body fiber; IDA:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0003865; F:3-oxo-5-alpha-steroid 4-dehydrogenase activity; IDA:RGD.
DR   GO; GO:0047751; F:3-oxo-5alpha-steroid 4-dehydrogenase (NADP+) activity; ISO:RGD.
DR   GO; GO:0033218; F:amide binding; IPI:RGD.
DR   GO; GO:0030283; F:testosterone dehydrogenase [NAD(P)+] activity; ISS:UniProtKB.
DR   GO; GO:0006702; P:androgen biosynthetic process; IDA:RGD.
DR   GO; GO:0008209; P:androgen metabolic process; IDA:RGD.
DR   GO; GO:0018879; P:biphenyl metabolic process; IEP:RGD.
DR   GO; GO:0060348; P:bone development; IEP:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0018894; P:dibenzo-p-dioxin metabolic process; IEP:RGD.
DR   GO; GO:0030540; P:female genitalia development; IEP:RGD.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0021854; P:hypothalamus development; IEP:RGD.
DR   GO; GO:0030539; P:male genitalia development; IEP:RGD.
DR   GO; GO:0008584; P:male gonad development; IEP:RGD.
DR   GO; GO:0018963; P:phthalate metabolic process; IEP:RGD.
DR   GO; GO:1904614; P:response to biphenyl; IDA:RGD.
DR   GO; GO:0032354; P:response to follicle-stimulating hormone; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IDA:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0033574; P:response to testosterone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0007548; P:sex differentiation; TAS:RGD.
DR   GO; GO:0006694; P:steroid biosynthetic process; IDA:RGD.
DR   GO; GO:0006706; P:steroid catabolic process; IDA:RGD.
DR   GO; GO:0061370; P:testosterone biosynthetic process; ISS:UniProtKB.
DR   Gene3D; 1.20.120.1630; -; 1.
DR   InterPro; IPR016636; 3-oxo-5-alpha-steroid_4-DH.
DR   InterPro; IPR001104; 3-oxo-5_a-steroid_4-DH_C.
DR   InterPro; IPR039357; SRD5A/TECR.
DR   PANTHER; PTHR10556; 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; 1.
DR   PANTHER; PTHR10556:SF43; 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE 2; 1.
DR   Pfam; PF02544; Steroid_dh; 1.
DR   PIRSF; PIRSF015596; 5_alpha-SR2; 1.
DR   PROSITE; PS50244; S5A_REDUCTASE; 1.
PE   1: Evidence at protein level;
KW   Differentiation; Endoplasmic reticulum; Lipid metabolism; Membrane;
KW   Microsome; NADP; Oxidoreductase; Reference proteome;
KW   Sexual differentiation; Transmembrane; Transmembrane helix.
FT   CHAIN           1..254
FT                   /note="3-oxo-5-alpha-steroid 4-dehydrogenase 2"
FT                   /id="PRO_0000213680"
FT   TRANSMEM        8..28
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        72..92
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        146..166
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        206..226
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   254 AA;  28772 MW;  8874C533DF3BD123 CRC64;
     MQIVCHQVPV LAGSATLATM GTLILCLGKP ASYGKHTESV SSGVPFLPAR IAWFLQELPS
     FVVSVGMLAW QPRSLFGPPG NVLLALFSAH YFHRTFIYSL LTRGRPFPAV LFLRATAFCI
     GNGLLQAYYL VYCAEYPEEW YTDVRFSFGV FLFILGMGIN IHSDYTLRQL RKPGEVIYRI
     PRGGLFTYVS GANFLGEIIE WIGYALATWS VPAFAFAFFT LCFLGMQAFY HHRFYLKMFK
     DYPKSRKALI PFIF
//
